Janus Henderson Group’s Elanco Animal Health ELAN Stock Holding History

Janus Henderson Group’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.41M	Buy	226,000 +10,600	+5%	+$259K	﹤0.01%	933
2025 Q4	$4.87M	Hold	215,400	–	–	﹤0.01%	948
2025 Q3	$4.34M	Hold	215,400	–	–	﹤0.01%	965
2025 Q2	$3.08M	Hold	215,400	–	–	﹤0.01%	1097
2025 Q1	$2.24M	Sell	215,400 -12,000	-5%	-$136K	﹤0.01%	1216
2024 Q4	$2.75M	Sell	227,400 -8,600	-4%	-$113K	﹤0.01%	1149
2024 Q3	$3.47M	Hold	236,000	–	–	﹤0.01%	1036
2024 Q2	$3.4M	Sell	236,000 -2,521	-1%	-$40.3K	﹤0.01%	1004
2024 Q1	$3.88M	Sell	238,521 -12	-0%	-$188	﹤0.01%	977
2023 Q4	$3.56M	Sell	238,533 -463	-0.2%	-$5.24K	﹤0.01%	961
2023 Q3	$2.69M	Sell	238,996 -21,482	-8%	-$249K	﹤0.01%	1036
2023 Q2	$2.62M	Sell	260,478 -4,616,159	-95%	-$42.8M	﹤0.01%	1111
2023 Q1	$45.8M	Sell	4,876,637 -7,101,218	-59%	-$83.8M	0.03%	397
2022 Q4	$146M	Sell	11,977,855 -78,841	-0.7%	-$983K	0.1%	194
2022 Q3	$150M	Buy	12,056,696 +95,147	+0.8%	+$1.66M	0.11%	189
2022 Q2	$235M	Sell	11,961,549 -350,322	-3%	-$8.29M	0.16%	153
2022 Q1	$321M	Buy	12,311,871 +715,654	+6%	+$19.1M	0.16%	154
2021 Q4	$329M	Sell	11,596,217 -586,244	-5%	-$18.2M	0.14%	168
2021 Q3	$388M	Sell	12,182,461 -7,029,791	-37%	-$236M	0.17%	137
2021 Q2	$666M	Sell	19,212,252 -8,944,436	-32%	-$295M	0.29%	87
2021 Q1	$829M	Sell	28,156,688 -6,710,380	-19%	-$206M	0.38%	59
2020 Q4	$1.07B	Sell	34,867,068 -1,014,177	-3%	-$30.9M	0.5%	35
2020 Q3	$1B	Buy	35,881,245 +2,449,102	+7%	+$62.1M	0.52%	36
2020 Q2	$717M	Buy	33,432,143 +2,643,285	+9%	+$58.4M	0.4%	47
2020 Q1	$689M	Buy	30,788,858 +20,846,120	+210%	+$571M	0.47%	40
2019 Q4	$293M	Buy	9,942,738 +2,885,708	+41%	+$78.4M	0.15%	158
2019 Q3	$188M	Sell	7,057,030 -113,481	-2%	-$3.4M	0.1%	212
2019 Q2	$242M	Sell	7,170,511 -1,108,234	-13%	-$36M	0.13%	183
2019 Q1	$265M	Buy	8,278,745 +6,546,483	+378%	+$201M	0.15%	172
2018 Q4	$54.6M	Sell	1,732,262 -244,654	-12%	-$8.01M	0.03%	513
2018 Q3	$69M	Buy	+1,976,916	New	+$69.5M	0.04%	495

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Janus Henderson Group's ELAN Position: Q1 2026 in Review

Janus Henderson Group increased its Elanco Animal Health (ELAN) stake by 4.9% in Q1 2026, buying an estimated $259K and bringing the position to 226,000 shares worth $5.41M. The position accounts for ﹤0.01% of the portfolio, ranked #933.

Janus Henderson Group first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $1.07B in Q4 2020. 518 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

Janus Henderson Group held 226,000 shares of Elanco Animal Health worth $5.41M as of Q1 2026.
Janus Henderson Group bought 10,600 Elanco Animal Health shares in Q1 2026, an estimated $259K.
Elanco Animal Health made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #933 holding.
Janus Henderson Group first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
Janus Henderson Group's Elanco Animal Health position peaked at $1.07B in Q4 2020.
518 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.